Evidence map›Paper›PMID 34822395›Full record

ArticleMetabolites2021

Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted

Emma J Robinson, Matthew C Taddeo, Xin Chu, Weixing Shi, Craig Wood, Christopher Still, Virginia G Rovnyak, David Rovnyak

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Emma J RobinsonDepartment of Chemistry, Bucknell University, 1 Dent Drive, Lewisburg, PA 17837, USA.
Matthew C TaddeoDepartment of Chemistry, Bucknell University, 1 Dent Drive, Lewisburg, PA 17837, USA.
Xin ChuThe Obesity Institute, Geisinger, Danville, PA 17822, USA.
Weixing ShiThe Obesity Institute, Geisinger, Danville, PA 17822, USA.
Craig WoodThe Obesity Institute, Geisinger, Danville, PA 17822, USA.
Christopher StillThe Obesity Institute, Geisinger, Danville, PA 17822, USA.
Virginia G RovnyakUniversity of Virginia School of Nursing, Charlottesville, VA 22908, USA.
David RovnyakDepartment of Chemistry, Bucknell University, 1 Dent Drive, Lewisburg, PA 17837, USA.ORCID 0000-0003-0328-5083
Bucknell University · USUniversity of Virginia · US

Funding

Bucknell-Geisinger Research Partnership Phase II AwardNational Science Foundation MRI-0521108
6 · The paper itself

Abstract

Determining biomarkers and better characterizing the biochemical progression of nonalcoholic fatty liver disease (NAFLD) remains a clinical challenge. A targeted

Indexed as

bariatric surgerymetabolomicsNAFLDNMRnonalcoholic fatty liver diseasenuclear magnetic resonanceobesity

Identifiers

PMID34822395
PMCPMC8619318
OpenAlexW3209417164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.